KINIKSA PHARMACEUTICALS INTE
KNSANASDAQ🏆 #1208 by market capEarnings Oct 26US Equity
$1,003.79▼ $49.59 (−4.94%)
Simulated priceTrack KNSA
Get earnings, price moves & breaking news on Telegram
24h▼ 4.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$5.77B
Small Cap
📈Revenue Growth (YoY)
+60.1%
High Growth
📊Gross Margin
54.5%
Healthy
💵FCF Margin
21.8%
Strong
⚖️P/S Ratio
6.9x
Fair
Otter Score
56
Weak
🔭
No analyst ratings for KNSA
We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.